Stock listing
BVS Stock Price, News, Filings & Events — Bioventus Inc.
Selected listing: BVS · NASDAQ · USD · US
This page tracks Bioventus Inc.'s BVS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BVS:NASDAQ. BVS:NASDAQ is the stock-level entry point for investors researching Bioventus Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioventus Inc. is a public company traded under the ticker BVS in the American market. The company has a market capitalization of approximately $985.7 million. Bioventus focuses on developing innovative solutions for musculoskeletal health, aiming to improve patient outcomes through advanced technologies and therapies.
- Ticker
- BVS:NASDAQ
- Asset type
- Stock
- Market cap
- $1.21B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Bioventus Inc. BVS:NASDAQ stock context
This page tracks Bioventus Inc.'s BVS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BVS:NASDAQ. BVS:NASDAQ is the stock-level entry point for investors researching Bioventus Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioventus Inc. is a public company traded under the ticker BVS in the American market. The company has a market capitalization of approximately $985.7 million. Bioventus focuses on developing innovative solutions for musculoskeletal health, aiming to improve patient outcomes through advanced technologies and therapies.
Latest news from Bioventus Inc.
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
July 29, 2026
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
June 2, 2026
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Pro...
April 30, 2026
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
April 28, 2026
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
March 5, 2026
Bioventus Inc. earnings calls
Bioventus Inc. (BVS) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Bioventus Inc. (BVS) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Bioventus Inc. (BVS) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
Bioventus Inc. (BVS) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Bioventus Inc. (BVS) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Bioventus Inc. (BVS) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Bioventus Inc.
Bioventus Inc. investor report
Review AI stock analysis and investor report context for BVS:NASDAQ.
Bioventus Inc. company profile
View the public company page for Bioventus Inc. on 6ix.
Bioventus Inc. news
Read company news and market updates connected to Bioventus Inc..
Bioventus Inc. investor events
Find investor webinars, events, and replay context for Bioventus Inc..